Glyco-engineered pentameric SARS-CoV-2 IgMs show superior activities compared to IgG1 orthologues
Somanath Kallolimath, Roman Palt, Esther Föderl-Höbenreich, Lin Sun, Qiang Chen, Florian Pruckner, Lukas Eidenberger, Richard Strasser, Kurt Zatloukal, Herta Steinkellner
This study expresses glycoengineered pentameric SARS-CoV-2 IgMs in plants, showing 390-fold increased neutralization potency compared to IgG1 orthologues.
Frontiers in Immunology · Jun 8, 2023Peer-reviewedMolecular Biology